Arca
Skip to content
Tools
Tools

Ventricular fibrillation

Drug research and approvals for ventricular fibrillation: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 55 studies of ventricular fibrillation are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 2 approved and 2 open orphan designations naming it.

  • Recruiting worldwide: 55
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 2
  • EU medicines: 0

Recruiting now

Newest posted first, of 55 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 2

Phase 3 7

Phase 2 3

How its trials ended

147 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 36 whose ending is known, 44% met their primary endpoint, 14% missed it and 42% stopped early.

  • Completed, result not reported6645%
  • Status unknown2416%
  • Ongoing2114%
  • Met its primary endpoint1611%
  • Missed its primary endpoint53%
  • Stopped: other or unclear53%
  • Stopped: enrollment or feasibility43%
  • Stopped: lack of efficacy21%
  • Stopped: sponsor or business decision21%
  • Stopped: funding21%

FDA orphan designations

Approved first, then open designations, newest first
Jul 2, 2009So-AqueousFor use as a substitute for oral sotalol in patients who are unable to take sotalol orally [oral sotalol is indicated for maintenance of…AltaThera Pharmaceuticals LLCApproved
Aug 3, 1995CordaroneFor initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular…Wyeth-Ayerst LaboratoriesApproved
Nov 24, 1989Bethanidine sulfatePrevention of recurrence of primary ventricular fibrillation.Medco Research, Inc.Designated
Sep 20, 1988Bethanidine sulfateTreatment of primary ventricular fibrillation.Medco Research, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.